BIVIX (BIVIX) Stock Price & Analysis
BIVIX (BIVIX) rose 2.44% to USD 15.94 as of June 10, 2026 at 21:31 UTC, according to Nexqual real-time market data.
BIVIX last closed at USD 15.56; the session ranged USD 15.94–15.94 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 14.98–18.89 (NAS). Source: Nexqual, June 10, 2026 at 21:31 UTC.
Key Statistics (as of June 10, 2026 at 21:31 UTC)
| Price | USD 15.94 |
|---|---|
| Change | ▲ 2.44% (up) |
| Previous Close | USD 15.56 |
| Open | USD 15.94 |
| Day Range | USD 15.94 – 15.94 |
| 52-Week Range | USD 14.98 – 18.89 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (BIVIX)
Nexqual's technical model rates BIVIX "SELL" based on 2 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 21:31 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 51.68 (neutral) |
| vs SMA50 | Below (USD 16.43) |
| MACD | -0.21 (negative) |
Financial Health Score (BIVIX)
Nexqual rates BIVIX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 21:31 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIVRX | Invenomic Fund Investor Class | USD 15.6 | ▲ 2.36% |
| BIVSX | Invenomic Fund Super Institutio | USD 16.18 | ▲ 2.41% |
| QLEIX | AQR Long-Short Equity Fund Clas | USD 20.9 | ▼ 0.33% |
| HMEZX | Nexpoint Merger Abritrage Fund | USD 20.02 | ▼ 0.15% |
| MBXIX | Catalyst/Millburn Hedge Strateg | USD 46.11 | ▼ 0.17% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 21:31 UTC. This page is informational and not investment advice.